Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-12T19:36:24.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    New history entry 'Revision: v3.4.2' was added and an earlier 'Revision: v3.4.1' entry plus a site-wide funding notice were removed. These changes affect only the history metadata and do not modify study data or core page content.
    Difference
    0.7%
    Check dated 2026-02-11T20:36:51.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The additions include a site-wide notice about government funding status and a new revision label (v3.4.1), and the previous revision (v3.4.0) was removed; these are metadata changes and do not affect the study's record content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:54:01.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Changes are UI/formatting updates (glossary display option, color-coded highlights for additions and deletions, and the revision label updated to v3.4.0); there is no impact on core study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-28T07:24:35.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The record history shows a new Revision: v3.3.4 replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:49:40.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new revision entry (v3.3.3) was added to the record history, and the HHS Vulnerability Disclosure and a prior revision link were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:20:22.000Z thumbnail image

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.